Christopher Parker
Geen lopende functies
Vermogen: 20 460 $ op 30-04-2024
Profiel
Christopher Parker served as the Managing Director for Roche Diagnostics Ltd.
from 2012 to 2017 and later as the Executive Director for AnteoTech Ltd.
from 2022 to 2023.
He received his undergraduate degree from Queensland University of Technology.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
ANTEOTECH LTD
0.06% | 27-06-2023 | 1 500 000 ( 0.06% ) | 20 460 $ | 30-04-2024 |
Eerdere bekende functies van Christopher Parker
| Bedrijven | Functie | Einde |
|---|---|---|
| ANTEOTECH LIMITED | Algemeen Directeur | 01-12-2019 |
Roche Diagnostics Ltd.
 Roche Diagnostics Ltd. Medical SpecialtiesHealth Technology Roche Diagnostics Ltd. manufactures equipment and reagents for research and medical diagnostic applications. The company was founded on September 14, 1956 and is headquartered in Burgess Hill, the United Kingdom. | Corporate Officer/Principal | 01-07-2017 |
Opleiding van Christopher Parker
| Queensland University of Technology | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| ANTEOTECH LIMITED | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Roche Diagnostics Ltd.
Roche Diagnostics Ltd. Medical SpecialtiesHealth Technology Roche Diagnostics Ltd. manufactures equipment and reagents for research and medical diagnostic applications. The company was founded on September 14, 1956 and is headquartered in Burgess Hill, the United Kingdom. | Health Technology |
